Struggling diagnostics company Provalis is selling its remaining business in diabetes testing and will put itself into liquidation. Its shares tumbled from 0.75p to 0.32p after the company said it had ...

Sarbanes-Oxley is forcing pharma company Provalis to delist from Nasdaq just as its US business starts to take off. As Husnara Begum finds, the move is keeping its sole lawyer busy Medical diagnostics ...

DEESIDE healthcare company Provalis has signed an exclusive deal to distribute a respiratory treatment drug in the UK and Ireland. DEESIDE healthcare company Provalis has signed an exclusive deal to ...

DEESIDE Industrial Park-based healthcare company Provalis is to sell its pharmaceutical business to Northern Ireland-based Galen Ltd for £10.5m. Forty jobs will be lost in the move with redundancy ...

HEALTHCARE company Provalis has been awarded £1.6m after arbitration over a disputed contract decided in its favour. HEALTHCARE company Provalis has been awarded #1.6m after arbitration over a ...

SHAREHOLDERS in Deeside-based healthcare company Provalis have approved the £10.5m sale of its pharmaceutical arm in a move that will give the company cash to enhance a medical diagnostic product.

It looks like the year-end has come a bit too soon for drug company Provalis. A disappointing fourth quarter, in which revenues were around 20 per cent below previous expectations, will have a ...